| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0004 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.23 | 0.004 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |